SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-088592
Filing Date
2007-12-13
Accepted
2007-12-13 09:05:27
Documents
7
Period of Report
2007-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-31264_18k.htm 8-K 42699
2 EX-1.01 a07-31264_1ex1d01.htm EX-1.01 327817
3 EX-4.5 a07-31264_1ex4d5.htm EX-4.5 87828
4 EX-5.1 a07-31264_1ex5d1.htm EX-5.1 17420
5 EX-99.1 a07-31264_1ex99d1.htm EX-99.1 104718
6 EX-99.2 a07-31264_1ex99d2.htm EX-99.2 8333
7 GRAPHIC g312641kgi001.gif GRAPHIC 1209
  Complete submission text file 0001104659-07-088592.txt   592323
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 071303328
SIC: 2834 Pharmaceutical Preparations